Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Ipsen S.A. ADR (IPSEY)
Ipsen S.A. ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 9,514,679
  • Shares Outstanding, K 335,260
  • Annual Sales, $ 3,326 M
  • Annual Income, $ 683,360 K
  • 60-Month Beta 0.86
  • Price/Sales N/A
  • Price/Cash Flow 8.08
  • Price/Book 2.92
Trade IPSEY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/10/23
  • Annual Dividend & Yield 0.23 (0.81%)
  • Most Recent Dividend 0.231 on 06/02/23
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.6400 +0.07%
on 12/01/23
30.0600 -7.98%
on 11/06/23
-1.5600 (-5.34%)
since 11/03/23
3-Month
27.6400 +0.07%
on 12/01/23
34.3380 -19.45%
on 09/13/23
-4.1750 (-13.11%)
since 09/01/23
52-Week
25.0900 +10.24%
on 12/27/22
34.3380 -19.45%
on 09/13/23
-0.4000 (-1.43%)
since 12/02/22

Most Recent Stories

More News
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 27.6600 (-2.54%)
3 Pharma Stocks Providing Consistent Gains for Investors

The pharmaceutical industry is anticipated to be bolstered due to the increasing demand for chronic disease management and the rising requirements of an aging demographic. Given the industry’s solid...

ETON : 3.66 (-1.22%)
IPSEY : 27.6600 (-2.54%)
MRK : 104.94 (+1.43%)
Which of These 3 Pharma Stocks Are a Buy?

The pharma industry is expected to experience substantial growth in the coming years with expanding global medical needs. So, which of these pharma stocks, Ipsen (IPSEY), Collegium Pharmaceutical (COLL),...

COLL : 26.06 (+1.80%)
IPSEY : 27.6600 (-2.54%)
SNDL : 1.5350 (+2.33%)
3 Undervalued Pharma Stocks Worth Buying

With the growing prevalence of chronic diseases, the adoption of advanced digital technologies, and new drug discoveries, the pharmaceutical industry is set to witness significant growth this year and...

IPSEY : 27.6600 (-2.54%)
KMDA : 4.77 (+2.58%)
SUPN : 27.97 (+1.41%)
UBS : 28.44 (-0.84%)
2 Pharma Stocks to Watch Like a Hawk

From innovative drug pipelines to innovative research, the pharma sector offers a vast array of investment opportunities. Thus it would be wise to keep an eye on quality stocks Ipsen S.A.(IPSEY) and Kamada...

IPSEY : 27.6600 (-2.54%)
KMDA : 4.77 (+2.58%)
Is Cybin Inc. (CYBN) Stock Outpacing Its Medical Peers This Year?

Here is how Cybin Inc. (CYBN) and IPSEN (IPSEY) have performed compared to their sector so far this year.

CYBN : 0.4396 (-4.43%)
IPSEY : 27.6600 (-2.54%)
Is IPSEN (IPSEY) Outperforming Other Medical Stocks This Year?

Here is how IPSEN (IPSEY) and Thermo Fisher Scientific (TMO) have performed compared to their sector so far this year.

IPSEY : 27.6600 (-2.54%)
TMO : 496.62 (+0.10%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

Regulatory News:

OTC.VN : 0.330 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 27.6600 (-2.54%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

Regulatory News:

OTC.VN : 0.330 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 27.6600 (-2.54%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

AZN : 64.89 (+0.15%)
IPSEY : 27.6600 (-2.54%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 29.3667
2nd Resistance Point 28.8733
1st Resistance Point 28.6267
Last Price 27.6600
1st Support Level 27.8867
2nd Support Level 27.3933
3rd Support Level 27.1467

See More

52-Week High 34.3380
Fibonacci 61.8% 30.8053
Fibonacci 50% 29.7140
Fibonacci 38.2% 28.6227
Last Price 27.6600
52-Week Low 25.0900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar